On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Microbionta, S.l.'s own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€533k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ANTIPATHOGNPartner
Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€533ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universitat Autonoma de BarcelonaSpain · 1 shared project
- Deutsches Krebsforschungszentrum HeidelbergGermany · 1 shared project
- Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 1 shared project
- Fundacio Institut de Recerca Biomedica (Irb Barcelona)Spain · 1 shared project
- Helmholtz-Zentrum Fur Infektionsforschung GmbHGermany · 1 shared project
- Anaxomics Biotech SLSpain · 1 shared project
- Bio-Xtal SARLFrance · 1 shared project
- PROTEROS BIOSTRUCTURES GmbHGermany · 1 shared project
- InterMed Discovery GmbHGermany · 1 shared project
- Rps Research Iberica SLSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- bacteriology
- clinical microbiology
- drug discovery
- drug resistance
- structural biology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗